JPS5877883A - オキサゾリジンジオン誘導体 - Google Patents

オキサゾリジンジオン誘導体

Info

Publication number
JPS5877883A
JPS5877883A JP57179684A JP17968482A JPS5877883A JP S5877883 A JPS5877883 A JP S5877883A JP 57179684 A JP57179684 A JP 57179684A JP 17968482 A JP17968482 A JP 17968482A JP S5877883 A JPS5877883 A JP S5877883A
Authority
JP
Japan
Prior art keywords
group
hydrogen
spiro
oxazolidine
indoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57179684A
Other languages
English (en)
Japanese (ja)
Other versions
JPS611073B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
アラン・ジエフリ−・ハツチソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Inc
Original Assignee
Pfizer Corp Belgium
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Inc filed Critical Pfizer Corp Belgium
Publication of JPS5877883A publication Critical patent/JPS5877883A/ja
Publication of JPS611073B2 publication Critical patent/JPS611073B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP57179684A 1981-10-13 1982-10-13 オキサゾリジンジオン誘導体 Granted JPS5877883A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31068281A 1981-10-13 1981-10-13
US310682 1981-10-13

Publications (2)

Publication Number Publication Date
JPS5877883A true JPS5877883A (ja) 1983-05-11
JPS611073B2 JPS611073B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-01-13

Family

ID=23203647

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57179684A Granted JPS5877883A (ja) 1981-10-13 1982-10-13 オキサゾリジンジオン誘導体

Country Status (16)

Country Link
EP (1) EP0079675A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5877883A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR860000486B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR231839A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU531161B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1171860A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK449882A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8400116A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI823480L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR77019B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU185113B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL66954A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH18038A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL238595A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT75673B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU229382A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
EP0159143B1 (en) * 1984-03-23 1987-12-16 Pfizer Inc. Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
WO1988009661A1 (en) * 1987-06-10 1988-12-15 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US5221686A (en) * 1992-08-04 1993-06-22 American Home Products Corporation Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
CN102336769A (zh) * 2011-07-06 2012-02-01 华东理工大学 一种简便的合成螺[氧化吲哚-3,5'-噁唑啉]杂环化合物的新方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones

Also Published As

Publication number Publication date
AU531161B2 (en) 1983-08-11
ES515751A0 (es) 1983-10-16
CA1171860A (en) 1984-07-31
KR860000486B1 (ko) 1986-04-30
FI823480A7 (fi) 1983-04-14
FI823480A0 (fi) 1982-10-12
IL66954A (en) 1985-02-28
PT75673B (en) 1985-12-09
PL238595A1 (en) 1983-09-12
DK449882A (da) 1983-04-14
EP0079675A1 (en) 1983-05-25
KR840002002A (ko) 1984-06-11
PT75673A (en) 1982-11-01
AR231839A1 (es) 1985-03-29
JPS611073B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-01-13
ES8400116A1 (es) 1983-10-16
PH18038A (en) 1985-03-08
YU229382A (en) 1984-12-31
HU185113B (en) 1984-12-28
FI823480L (fi) 1983-04-14
IL66954A0 (en) 1983-02-23
AU8928882A (en) 1983-04-21
GR77019B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-04

Similar Documents

Publication Publication Date Title
JP3708957B2 (ja) (−)−エゼロリン、(−)−n1−ノルエゼロリンおよび(−)−n1−ベンジルノルエゼロリンの置換フェンゼリンおよびフェニルカルバミン酸塩:特異的アセチルコリンエステラーゼ阻害薬としての使用
JPS60109558A (ja) スルフアメ−トおよび医薬としてのその用途
EP0252713A1 (en) Indolinone derivatives
RU2042663C1 (ru) Производные бензола и их соли
JP2000515168A (ja) スピロ環メタロプロテアーゼ阻害剤
IE50895B1 (en) Hydantoin amines and pharmaceutical compositions thereof
JPS5940388B2 (ja) ヒダントイン誘導体治療剤
JP3053490B2 (ja) チアゾリジン−2,4−ジオン誘導体とその塩及び製造法
HU184712B (en) Process for producing dextrorotating trans-2-substituted-5-phenyl-2,3,4,4a,5,9b,hexahydro-h-pyrido-bracket-4,3,b-bracket closedindol derivatives
US4113866A (en) Analgetic compounds, compositions and process of treatment
House et al. Stereochemistry of the N-Alkylation of 4-t-Butylpiperidine Derivatives1a
JPS5877883A (ja) オキサゾリジンジオン誘導体
CN100522959C (zh) 一类6-芳基-3-环氨基甲基吡喃酮类衍生物的制备及用途
JPH07505120A (ja) チアフィゾベニンのカルバミン酸類縁化合物、医薬品用組成物、ならびにコリンエステラーゼ阻害方法
LU86421A1 (fr) Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention
EP0646110B1 (de) N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika
US4464380A (en) Imidazolidinedione derivatives
US4209527A (en) Benzimidazolone derivatives
EP0266102A2 (en) Quinoxalinone derivatives
IL88114A (en) Benzothiazine dioxide derivatives and pharmaceutical compositions containing them
KR860001581B1 (ko) 스피로-3-헤테로-아졸론의 제조방법
JPH06128228A (ja) インドール誘導体
US5064852A (en) Indolinone derivatives
RU2124516C1 (ru) Тетрагидроизохинолинкарбаматы 1,2,3,3а,8,8а-гексагидро-1,3а-8-триметилпирроло (2,3-b)индола, фармацевтическая композиция и способ ингибирования ацетилхолинэстеразы
US4533667A (en) Imidazolidinedione derivatives